Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NVDA vs GSK✓SelectedUSD · GSKNVDA vs GSK performance historyLatest closeAs of-4.12%11/16
Stock and ETF performance explorer

NVDA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+419.2%
GSK return
+46.9%
Excess return
+372.3%
Maximum drawdown
-66.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.1%-0.1%-4.0%-4.1%
7D-12.6%-1.3%-11.3%-12.6%
30D-27.1%+2.7%-29.8%-27.2%
3M-30.6%+2.7%-33.3%-30.7%
6M-30.5%+3.3%-33.9%-30.8%
YTD-16.1%+6.5%-22.5%-16.7%
1Y-17.7%+10.7%-28.4%-18.6%
3Y+216.5%+64.4%+152.2%+185.7%
5Y+419.2%+46.7%+372.5%+333.8%
All+419.2%+46.9%+372.3%+333.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling